ARCHIVES

Center Grant Review Tougher, Yarbro Insists

This article is from The Cancer Letter archive.

Vol. 01 No. 21 | May 23, 1975

Download PDF Visit The Full Archive

Related Articles

Sunitinib Prolongs Survival In Poor Prognosis, Study Finds

July 31, 2009

DCCP Board Okays Concepts For Severn Contract Recompetitions, Denies Two Other

June 19, 1981

NCI Advises Five-Year Limit On Tamoxifen Use, in Letter To Doctors

December 8, 1995

Hollings Cancer Center at MUSC Wins NCI Designation

March 6, 2009

FDA Authority To Remove Paclitaxel Patent Questioned.

February 9, 2001

Also NCI appoints members of Clinical Trials Working Group to review trials system.

January 9, 2004